Pituitary dysfunction after traumatic brain injury: screening and hormone replacement

References

• Cyran E. [Pituitary damage by skull base fracture]. Deutsche Medizinische Wochenschrift44, 1261 (1918).
   Google Scholar
• Kelly DF, Gonzalo IT, Cohan P, Berman N, Swerdloff R, Wang C. Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report. J. Neurosurg.93, 743–752 (2000).
   PubMed Web of Science ®Google Scholar
• Lieberman SA, Oberoi AL, Gilkison CR, Masel BE, Urban RJ. Prevalence of neuroendocrine dysfunction in patients recovering from traumatic brain injury. J. Clin. Endocrinol. Metab.86(6), 2752–2756 (2001).
   PubMed Web of Science ®Google Scholar
• Aimaretti G, Ambrosio MR, Di Somma C et al. Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study. J. Clin. Endocrinol. Metab.90(11), 6085–6092 (2005).
   PubMed Web of Science ®Google Scholar
• Leal-Cerro A, Flores JM, Rincon M, et al. Prevalence of hypopituitarism and growth hormone deficiency in adults long-term after severe traumatic brain injury. Clin. Endocrinol.62(5), 525–532 (2005).
   PubMed Web of Science ®Google Scholar
• Klose M, Juul A, Poulsgaard L, Kosteljanetz M, Brennum J, Feldt-Rasmussen U. Prevalence and predictive factors of post-traumatic hypopituitarism. Clin. Endocrinol.67(2), 193–201 (2007).
   PubMed Web of Science ®Google Scholar
• Kleindienst A, Brabant G, Bock C, Maser-Gluth C, Buchfelder M. Neuroendocrine function following traumatic brain injury and subsequent intensive care treatment. A prospective longitudinal evaluation. J. Neurotrauma26(9), 1435–1446 (2009).
   PubMed Web of Science ®Google Scholar
• Agha A, Sherlock M, Phillips J, Tormey W, Thompson C. The natural history of post-traumatic neurohypophysial dysfunction. Eur. J. Endocrinol.152, 371–377 (2005).
   PubMed Web of Science ®Google Scholar
• Agha A, Thornton E, O’Kelly P, Tormey W, Philips J, Thompson C. Posterior pituitary dysfunction after traumatic brain injury. J. Clin. Endocrinol. Metab.89(12), 5987–5992 (2004).
   PubMed Web of Science ®Google Scholar
• Schneider HJ, Kreitschmann-Andermahr I, Ghigo E, Stalla GK, Agha A. Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review. JAMA298(12), 1429–1438 (2007).
   PubMed Web of Science ®Google Scholar
• van der Eerden AW, Twickler MT, Sweep FC et al. Should anterior pituitary function be tested during follow-up of all patients presenting at the emergency department because of traumatic brain injury? Eur. J. Endocrinol.162, 19–28 (2010).
   PubMed Web of Science ®Google Scholar
• Tanriverdi F, Senyurek H, Unluhizarci H, Selcuklu A, Casaneuva FF, Kelestimur F. High risk of hypopituitarsim after traumatic brain injury: a prospective investigation of anterior pituitary function in the acute phase and 12 months after trauma. J. Clin. Endocrinol. Metab.91(6), 2105–2111 (2006).
   PubMed Web of Science ®Google Scholar
• Schneider HJ, Schneider M, Saller B et al. Prevalence of anterior pituitary insufficiency 3 and 12 months after traumatic brain injury. Eur. J. Endocrinol.154, 259–265 (2006).
   PubMed Web of Science ®Google Scholar
• Einaudi S, Matarazzo P, Peretta P. Hypothalamo-hypophysial dysfunction after traumatic brain injury in children and adolescents: a preliminary retrospective and prospective study. J. Pediatr. Endocrinol. Metab.19(5), 691–704 (2006).
   PubMed Web of Science ®Google Scholar
• Niederland T, Makovi H, Gal V, Andreka B, Abraham CS, Kovacs J. Abnormalities of pituitary function after traumatic brain injury in children. J. Neurotrauma24(1), 119–127 (2007).
   PubMed Web of Science ®Google Scholar
• Norwood KW, DeBoer MD, Gurka MJ et al. Traumatic brain injury in children and adolescents: surveillance for pituitary dysfunction. Clin. Pediatr.49(11), 1044–1049 (2010).
   PubMed Web of Science ®Google Scholar
• Khadr SN, Crofton PM , Jones PA et al. Evaluation of pituitary function after traumatic brain injury in childhood. Clin. Endocrinol.73(5), 637–644 (2010).
   PubMedGoogle Scholar
• Tanriverdi F, Unluhizarci K, Cokesevim B, Selcuklu AM, Casanueva FF, Kelestimur F. Kickboxing sport as a new cause of traumatic brain injury-mediated hypopituitarism. Clin. Endocrinol.66, 360–366 (2007).
   PubMed Web of Science ®Google Scholar
• Tanriverdi F, Unluhizarci K, Kocyigit I et al. Brief communication: pituitary volume and function in competing and retired male boxers. Ann. Intern. Med.148(11), 827–831 (2008).
   PubMed Web of Science ®Google Scholar
• Tanriverdi F, Unluhizarci K, Kelestimur F. Pituitary function in patients with mild traumatic brain injury: a review of literature and proposal of screening strategy. Pituitary13(2), 146–153 (2010).
   PubMed Web of Science ®Google Scholar
• Kreitschmann-Andermahr I, Poll EM, Reineke A et al. Growth hormone deficient patients after traumatic brain injury – baseline characteristics and benefits after growth hormone replacement – an analysis of the German KIMS database. Growth Horm. IGF Res.18(6), 472–478 (2008).
   PubMed Web of Science ®Google Scholar
• Klose M, Watt T, Brennum J, Feldt-Rasmussen U. Post-traumatic hypopituitarism is associated with an unfavorable body composition and lipid profile, and decreased quality of life 12 months after injury. J. Clin. Endocrinol. Metab.92(10), 3861–3868 (2007).
   PubMed Web of Science ®Google Scholar
• High WM Jr, Briones-Galang M, Clark JA et al. Effect of growth hormone replacement therapy on cognition after traumatic brain injury. J. Neurotrauma27(9), 1565–1575 (2010).
   PubMed Web of Science ®Google Scholar
• Krahulik D, Zapletalova J, Frysak Z, Vaveka M. Dysfunction of hypothalamic–hypophysial axis after traumatic brain injury in adults. J. Neurosurgery113(3), 581–584 (2010).
   PubMed Web of Science ®Google Scholar
• Bavisetty S, McArthur DL, Dusick JR et al. Chronic hypopituitarism after traumatic brain injury: risk assessment and relationship to outcome. Neurosurgery62(5), 1080–1094 (2008).
   PubMed Web of Science ®Google Scholar
• Agha A, Ryan J, Sherlock M, Thompson CJ. Spontaneous recovery from post-traumatic hypopituitarism. Am. J. Phys. Med. Rehab.84(5), 381–385 (2005).
   PubMedGoogle Scholar
• Agha A, Philips J, O’Kelly P, Tomery W, Thompson CJ. The natural history of post traumatic hypopituitarism: implications for assessment and treatment. Am. J. Med.118(12), 1416 (2005).
   PubMedGoogle Scholar
• Gasco V, Prodam F , Pagano L et al. Hypopituitarsim following brain injury: when does it occur how best to test? Pituitary DOI: 10.1007/s11102-010-0235-6 (2010) (Epub ahead of print).
   Google Scholar
• Ghigo E, Masel B, Aimaretti G et al. Consensus guidelines on screening for hypopituitarism following traumatic brain injury. Brain Inj.19(9), 711–724 (2005).
   PubMed Web of Science ®Google Scholar
• Zgaljardic DJ, Guttikonda S, Grady J et al. Serum IGF-1 concentrations in a sample of patients with traumatic brain injury as a diagnostic marker of growth hormone secretory response to glucagon stimulation testing. Clin. Endocrinol.74(3), 365–369 (2011).
   PubMed Web of Science ®Google Scholar
• Hadjadj S, Faure-Gerard C, Ragot S et al. Diagnostic strategy for growth hormone deficiency: relevance of IGF-1 determination as a screening test. Ann. Endocrinol.68(6), 449–455 (2007).
   PubMedGoogle Scholar
• Berg C, Meinel T, Lahner H, Yuece A, Mann K, Petersenn S. Diagnostic utility of the glucagon stimulation test in comparison to the insulin tolerance test in patients following pituitary surgery. Eur. J. Endocrinol.162, 477–482 (2010).
   PubMed Web of Science ®Google Scholar
• Aimaretti G, Corneli G, Razzore P et al. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone–arginine as provocative tests for the diagnosis of GH deficiency in adults. J. Clin. Endocrinol. Metab.83(5), 1615–1618 (1998).
   PubMed Web of Science ®Google Scholar
• Biller BM, Samuels MH, Zagar A et al. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J. Clin. Endocrinol. Metab.87(5), 2067–2079 (2002).
   PubMed Web of Science ®Google Scholar
• Corneli G, Di Somma C, Prodam F et al. Cut-off limits of the GH response to GHRH plus arginine test and IGF-I levels for the diagnosis of GH deficiency in late adolescents and young adults. Eur. J. Endocrinol.157(6), 701–708 (2007).
   PubMedGoogle Scholar
• Kevin C, Yuen J, Beverly M, Biller K, Molitch ME, Cook DM. Is lack of recombinant growth hormone (GH)-releasing hormone in the United States a setback or time to consider glucagon testing for adult GH deficiency? J. Clin. Endocrinol. Metab.94(8), 2702–2707 (2009).
   PubMedGoogle Scholar
• Conceição FL, da Costa e Silva A, Leal Costa AJ, Vaisman M. Glucagon stimulation test for the diagnosis of GH deficiency in adults. J. Endocrinol. Invest.26(11), 1065–1070 (2003).
   PubMed Web of Science ®Google Scholar
• Aimaretti G, Baffoni C, DiVito L et al. Comparisons among old and new provocative tests of GH secretion in 178 normal adults. Eur. J. Endocrinol.142(4), 347–352 (2000).
   PubMedGoogle Scholar
• Arvat E, Maccario M, Di Vito L et al. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J. Clin. Endocrinol. Metab.86(3), 1169–1174 (2001).
   PubMed Web of Science ®Google Scholar
• Gomez JM, Espadero RM, Escobar-Jiminez F et al. Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults. Clin. Endocrinol.56(3), 329–334 (2002).
   PubMed Web of Science ®Google Scholar
• Marik PE, Paterson SM, Annane D et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit. Care Med.36(6), 1937–1949 (2008).
   PubMed Web of Science ®Google Scholar
• Karaca Z, Lale A, Tanriverdi F, Kula M, Unluhizarci K, Kelestimur F. The comparison of low and standard dose ACTH and glucagon stimulation tests in the evaluation of hypothalamo–pituitary–adrenal axis in healthy adults. Pituitary14(2), 134–140 (2011).
   PubMedGoogle Scholar
• Guerrero AF, Alfonso A. Traumatic brain injury-related hypopituitarism: a review and recommendations for screening combat veterans. Mil. Med.175(8), 574–580 (2010).
   PubMedGoogle Scholar
• Cohan P, Wang C, McArthur DL et al. Acute secondary adrenal insufficiency after traumatic brain injury: a prospective study. Crit. Care Med.33(10), 2358–2366 (2005).
   PubMed Web of Science ®Google Scholar
• Slawik M, Klawitter B, Meiser E et al. Thyroid hormone replacement for central hypothyroidism: a randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronine. J. Clin. Endocrinol. Metab.92, 4115–4122 (2007).
   PubMedGoogle Scholar
• Abs R, Feldt-Rasmussen U, Mattsson AF, Monson JP, Bengtsson BA, Goth MI. Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults – a KIMS database analysis. Eur. J. Endocrinol.155(1), 79–90 (2006).
   PubMed Web of Science ®Google Scholar
• Bengtsson BA, Abs R, Bennmarker H et al. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board. J. Clin. Endocrinol. Metab.84(11), 3929–3935 (1999).
   PubMed Web of Science ®Google Scholar
• Monson JP, Abs R, Bengtsson BA et al. Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database. Clin. Endocrinol.53(3), 281–289 (2000).
   PubMedGoogle Scholar
• Monson JP, Jonsson P. Aspects of growth hormone (GH) replacement in elderly patients with GH deficiency: data from KIMS. Horm. Res.60, 112–120 (2003).
   PubMedGoogle Scholar
• Fideleff HL, Boquete HR, Stalldecker G, Giaccio AV, Sobrado PG. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients. Growth Horm. IGF Res.18(4), 318–324 (2008).
   PubMed Web of Science ®Google Scholar
• Monson JP, Bengtsson BA, Abs R, Feldt-Rasmussen U, Wuster C. Can growth hormone therapy cause diabetes? KIMS Strategic Committee. Lancet355, 1728–1729 (2000).
   PubMed Web of Science ®Google Scholar
• Abs R, Mattsson AF, Bengtsson BA et al. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database. Growth Horm. IGF Res.15, 349–359 (2005).
   PubMed Web of Science ®Google Scholar
• Drake WM, Rodriguez-Arnao J, Weaver JU et al. The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study. Clin Endocrinol.54, 525–532 (2001).
   PubMedGoogle Scholar
• Jorgensen AP, Fougner KJ, Ueland T et al. Favorable long-term effects of growth hormone replacement therapy on quality of life, bone metabolism, body composition and lipid levels in patients with adult-onset growth hormone deficiency. Growth Horm. IGF Res.21(2), 69–75 (2011).
   PubMed Web of Science ®Google Scholar
• Ho KK; 2007 GH Deficiency Consensus Workshop Participants. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH research society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society and Endocrinology Society of Australia. Eur. J. Endocrinol.157, 695–700 (2007).
   PubMed Web of Science ®Google Scholar